Heidelberg Pharma AG Statistics
Total Valuation
LON:0QW5 has a market cap or net worth of GBP 191.56 million. The enterprise value is 173.88 million.
Market Cap | 191.56M |
Enterprise Value | 173.88M |
Important Dates
The last earnings date was Thursday, July 10, 2025.
Earnings Date | Jul 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 46.60M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.47% |
Shares Change (QoQ) | -5.70% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 9.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 33.81 |
PB Ratio | 9.24 |
P/TBV Ratio | 14.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -10.10 |
EV / Sales | 29.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.53 |
Financial Position
The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.
Current Ratio | 7.15 |
Quick Ratio | 4.78 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -592.23 |
Financial Efficiency
Return on equity (ROE) is -59.35% and return on invested capital (ROIC) is -40.11%.
Return on Equity (ROE) | -59.35% |
Return on Assets (ROA) | -26.48% |
Return on Invested Capital (ROIC) | -40.11% |
Return on Capital Employed (ROCE) | -51.33% |
Revenue Per Employee | 53,960 |
Profits Per Employee | -163,986 |
Employee Count | 105 |
Asset Turnover | 0.12 |
Inventory Turnover | 0.15 |
Taxes
Income Tax | -40,456 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.89% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.
Beta (5Y) | -0.28 |
52-Week Price Change | +61.89% |
50-Day Moving Average | 3.73 |
200-Day Moving Average | 3.34 |
Relative Strength Index (RSI) | 57.45 |
Average Volume (20 Days) | 186 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0QW5 had revenue of GBP 5.67 million and -17.22 million in losses. Loss per share was -0.37.
Revenue | 5.67M |
Gross Profit | 4.18M |
Operating Income | -20.05M |
Pretax Income | -17.26M |
Net Income | -17.22M |
EBITDA | -19.44M |
EBIT | -20.05M |
Loss Per Share | -0.37 |
Balance Sheet
The company has 17.10 million in cash and 125,583 in debt, giving a net cash position of 16.97 million.
Cash & Cash Equivalents | 17.10M |
Total Debt | 125,583 |
Net Cash | 16.97M |
Net Cash Per Share | n/a |
Equity (Book Value) | 20.72M |
Book Value Per Share | 0.44 |
Working Capital | 28.26M |
Cash Flow
In the last 12 months, operating cash flow was -22.67 million and capital expenditures -419,648, giving a free cash flow of -23.09 million.
Operating Cash Flow | -22.67M |
Capital Expenditures | -419,648 |
Free Cash Flow | -23.09M |
FCF Per Share | n/a |
Margins
Gross Margin | 73.80% |
Operating Margin | -353.88% |
Pretax Margin | -304.62% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LON:0QW5 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.47% |
Shareholder Yield | n/a |
Earnings Yield | -8.99% |
FCF Yield | -12.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.
Last Split Date | Nov 7, 2017 |
Split Type | Forward |
Split Ratio | 1.0464082038 |
Scores
LON:0QW5 has an Altman Z-Score of -6.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -6.89 |
Piotroski F-Score | 1 |